Cart
sales@molnova.com
T-3364366
CAS No. 1356354-09-0
T-3364366( T 3364366 | T3364366 )
Catalog No. M27929 CAS No. 1356354-09-0
Raclopride a selective antagonist of D2 dopamine receptor with Ki value of 1.8 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 50 | Get Quote |
|
| 5MG | 81 | Get Quote |
|
| 10MG | 132 | Get Quote |
|
| 25MG | 223 | Get Quote |
|
| 50MG | 332 | Get Quote |
|
| 100MG | 489 | Get Quote |
|
| 200MG | 698 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameT-3364366
-
NoteResearch use only, not for human use.
-
Brief DescriptionRaclopride a selective antagonist of D2 dopamine receptor with Ki value of 1.8 nM.
-
DescriptionRaclopride a selective antagonist of D2 dopamine receptor with Ki value of 1.8 nM.
-
In Vitro——
-
In Vivo——
-
SynonymsT 3364366 | T3364366
-
PathwayOthers
-
TargetOther Targets
-
Recptor5-LOX|LTB4|5-HETE
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1356354-09-0
-
Formula Weight443.46
-
Molecular FormulaC18H16F3N3O3S2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (281.87 mM)
-
SMILESCC(=O)NCCSc1nc2cscc2c(=O)n1-c1ccc(OCC(F)(F)F)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Lehmann B, et al. Croconazole: an inhibitor of eicosanoid synthesis in A23187-stimulated human polymorphonuclear leukocytes and human whole blood. Skin Pharmacol. 1995;8(6):326-33.
molnova catalog
related products
-
2-Hydroxy-3-methoxyb...
2-Hydroxy-3-methoxybenzoic acid glucose ester shows a potent antagonistic activity against platelet activating factor (PAF), it can prevent the mice from the PAF-induced death at a dose of 300 micrograms/mouse.
-
Lactiflorin
Lactiflorin is a monoterpene glycoside from paeony root. Lactiflorin possesses nephroprotective effect.
-
CL2A-SN-38 DCA 127...
CL2A-SN-38 is a drug-linker conjugate composed of a potent a DNA Topoisomerase I inhibitor SN-38 and a linker CL2A to make antibody drug conjugate (ADC).
